Vicky Brown Email

SVP, Head Rare Disease . Apellis Pharmaceuticals

Current Roles

Employees:
840
Revenue:
$256.3M
About
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases.
Apellis Pharmaceuticals Address
100 5th Avenue
Crestwood, KY
United States
Apellis Pharmaceuticals Email

Past Companies

Apellis PharmaceuticalsSenior Vice President, Head of Rare Disease
Apellis PharmaceuticalsVice President, Head of Global Commercial Strategy
BiogenSenior Director, MS Brand Team Lead

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.